Wang, Zheng
Li, Min
Jiang, Hongfei
Luo, Shudi
Shao, Fei
Xia, Yan
Yang, Mengke
Ren, Xiangle
Liu, Tong
Yan, Meisi
Qian, Xu
He, Haiyan
Guo, Dong
Duan, Yuran
Wu, Ke
Wang, Lei
Ji, Guimei
Shen, Yuli
Li, Lin
Zheng, Peixiang
Dong, Bofei
Fang, Jing
Zheng, Min
Liang, Tingbo
Li, Haitao
Yu, Rilei
Xu, Daqian
Lu, Zhimin http://orcid.org/0000-0002-2859-2736
Funding for this research was provided by:
National Natural Science Foundation of China (82173114, Z.W., 82188102, 82030074, Z.L.)
Ministry of Science and Technology of the People's Republic of China (2021YFA0805600, D.X., 2020YFA0803300, Z.L.)
Article History
Received: 20 June 2021
Accepted: 9 September 2022
First Online: 20 October 2022
Competing interests
: Z.L. owns shares in Signalway Biotechnology (Pearland, TX), which supplied the rabbit antibodies that recognize FBP1 pS170. Z.L.’s interest in this company had no bearing on its being chosen to supply these reagents. The remaining authors declare no competing interests.